公开(公告)号：AU2017358122B2

公开(公告)日：2022-12-22

申请号：AU2017358122

申请日：2017-09-28

Applicant: TOOLGEN INCORPORATED

Inventor： KIM SEOKJOONG ,  SONG DONG WOO ,  HONG YOUNG BIN ,  CHOI BYUNG OK ,  LEE JAE YOUNG ,  LEE JUNG MIN

IPC: C12N15/113 ,  A61K48/00 ,  C07K14/705 ,  C12N9/22 ,  C12N15/10 ,  C12N15/86

Abstract: The present invention relates to an artificially engineered SC function control factor for SC function control and/or the treatment or alleviation of a disease due to SC function disorder, and to a use thereof. More specifically, the present invention relates to a system capable of performing artificial SC function control and/or treating or alleviating a disease due to SC function disorder, the system comprising: an artificially engineered SC function control factor for SC function control and/or the treatment or alleviation of a disease due to SC function disorder; and/or a composition capable of artificially engineering an SC function control factor. In a specific aspect, the present invention relates to an SC function control system by an SC function control factor, such as artificially engineered PMP22, and/or an expression product thereof.

公开(公告)号：KR20180054427A

公开(公告)日：2018-05-24

申请号：KR20170126636

申请日：2017-09-28

Applicant: TOOLGEN INCORPORATED ,  SAMSUNG LIFE PUBLIC WELFARE FOUNDATION

Inventor： KIM SEOKJOONG ,  SONG DONG WOO ,  HONG YOUNG BIN ,  CHOI BYUNG OK ,  LEE JAE YOUNG ,  LEE JUNG MIN

IPC: C07K14/705 ,  A61K48/00 ,  C12N9/22 ,  C12N15/10 ,  C12N15/113 ,  C12N15/86

CPC classification number: C12N15/86 ,  C12N15/113 ,  C12N2310/20

Abstract: 본발명은 SC 기능조절및/또는 SC 기능장애로인한질환치료또는개선을위한, 인위적으로조작된 SC 기능조절인자및 이의이용에관한것이다. 보다구체적으로, SC 기능조절및/또는 SC 기능장애로인한질환치료또는개선을위한인위적으로조작된 SC 기능조절인자및/또는 SC 기능조절인자를인위적으로조작할수 있는조성물을포함하는, 인위적으로 SC 기능조절및/또는 SC 기능장애로인한질환치료또는개선할수 있는시스템에관한것이다. 구체적인양태로, 인위적으로조작된 PMP22 등의 SC 기능조절인자및/또는이의발현산물에의한 SC 기능조절시스템에관한것이다.